Reading MLAB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MLAB free→Reading MLAB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MLAB free→NASDAQInformation TechnologyScientific & Technical InstrumentsSnapshot 2026-06-15
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is neutral. Earnings quality cannot be assessed since the company was unprofitable over the past year. Management's recent track record has been fairly steady. Risk is elevated, and the sector backdrop is a tailwind. Compared with sector peers, MLAB is above typical. Peer multiples imply a price about 31% above where it trades (it looks cheap on this basis); the read is cheap, value-trap risk. This pattern occurs because it trades below peer multiples, but recent financials are weak. The read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $104.08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $104 MLAB trades at 21× p/e, below its 28× p/e peer median. Our $151 fair value sits above the price; high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 31% below a flat-multiple fair value, below our forecast of about 16%. This describes what's priced in, not a forecast of the move.
Only a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Information Technology names rated neutral grew net income 54% of the time over the next year (vs 68% for the rest of the cohort, n=3704).
Over the trailing year it converted -23.76x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
4 material management or governance events in the past 24 months, led by executive changes. Historically, Information Technology names rated neutral grew net income 64% of the time over the next year (vs 57% for the rest of the cohort, n=1040).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.06 → $2.55 (+140.6% / 30d). 1 raised, 0 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d. 33% of analysts rate Buy.
1 positive, 0 negative / 30d. See F4 management tile for the event list.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$176.
How much price usually moves either way.
On a bad day, this stock has moved -$537.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,445.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: If revenue growth falls below the median, it signals a weakening trend in the sector.
Confirms:Revenue growth drops below its median value for the sector.
Disproves:Revenue growth remains above the median value for the sector.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for MLAB yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 11, 2026, the board of directors (the “Board”) of Mesa Laboratories, Inc. (“Mesa” or the “Company”) approved the appointment of Lyndsey Crennen as the Chief Accounting Officer of the Company, effective as of her entry into the Employment Agreement described below. Ms. Crennen, age 41, has over 20 years of experience in accounting and relate…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
A side-by-side read on sector standing, valuation, and risk versus Electronic Equipment & Instruments.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
MLAB Mesa Laboratories, Inc. | Above typical Show detailsSector percentile: 90 of 100 | inexpensive | elevated |
KEYS Keysight Technologies | Above typical Show detailsSector percentile: 88 of 100 | expensive | moderate |
ROP Roper Technologies | Above typical Show detailsSector percentile: 96 of 100 | inexpensive | elevated |
TDY Teledyne Technologies | Above typical Show detailsSector percentile: 76 of 100 | full | moderate |
TRMB Trimble Inc. | Above typical Show detailsSector percentile: 94 of 100 | inexpensive | moderate |
Not investment advice. As of 2026-06-15.
via XLK
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Management aims to achieve positive core organic growth by the first quarter of 2027.
Newly stated in 2026-Q4. Management has set a target for positive core organic growth by 1Q27. However, the financials do not provide specific revenue figures for 2026-Q4, making it difficult to assess current progress towards this goal. The trajectory remains to be seen.
“We expect our overall revenues to return to positive core organic growth in 1Q27.”
Management reported achieving 3.4% organic revenue growth for the fiscal year 2026.
Newly stated in 2026-Q4. Management reported achieving 3.4% organic revenue growth for FY2026, with revenues reaching $249,130 million. This indicates a positive trajectory in line with their growth objectives.
“For the year, revenues were $249,130 which resulted in 3.4% organic (1.2% core organic) revenues growth.”
Management anticipated a sequential increase in revenues for the third quarter of 2026.
Newly stated in 2025-Q2. Management anticipated a sequential revenue increase for 3Q26. However, the financials do not provide specific revenue figures for 3Q26, making it difficult to assess the actual outcome. The trajectory remains uncertain.
“We expect revenues to sequentially increase in 3Q26.”
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 9, 2026, Mesa Laboratories, Inc. (“Mesa” or the “Company”) announced the departure of Gary Owens as President and Chief Executive Officer of the Company, effective on or about April 13, 2026. On March 20, 2026, Mr. Owens and the Company entered into a Retention and Transition Agreement (the “Transition Agreement”) pursuant to which he will…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. CEO Departure On March 3, 2026, Mesa Laboratories, Inc. (“Mesa” or the “Company”) initiated a leadership transition pursuant to which Gary Owens will depart as President and Chief Executive Officer of the Company, effective on or about April 13, 2026 (the “Transition Date”). Mr. Owens' separation from the Company is not the result of any disagreeme…
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.